INSIGHTS ON CLINICAL TRIAL PARTNERING

• The Agentic AI Readiness Myths Costing Sponsors Time

  Many clinical organizations believe they must clean data and unify systems before adopting agentic AI. New approaches show teams can start now, create value faster, and improve readiness as they scale.

• Are Your Trial Payments Creating Hidden Compliance Risks?

  Clear separation of reimbursements, stipends, and site payments helps reduce compliance risk, improve transparency, and support ethical compensation.

• Before You Invest: A Clinical Trial Payment Technology Checklist

  Outdated payment workflows create delays, financial blind spots, and administrative strain in clinical trials. Evaluating integrated, real-time solutions helps reduce burden, improve visibility, and support more efficient, scalable trial execution.

• Study Analysis – Site Payment Automation

  By removing administrative bottlenecks, see how automation improves cash flow for sites, reduces operational burden for sponsors, and supports smoother, more predictable trial execution.

• Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision Clinics

  3/11/2025

  Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.

• Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study

  1/6/2025

  Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO. 

• The Real Power Of Digital Payments In Clinical Trials

  10/8/2025

  Digital payments streamline clinical trials by reducing site burden, improving patient experience, eliminating manual delays, and delivering cleaner data across global studies.

• Do CROs Need To Reinvent Themselves In 2025?

  3/21/2025

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• Ergomed CRO Solutions Expo: Finding The Right Partner For Early-Stage Oncology Trials

  11/21/2025

  Learn how modern, model-based dose-finding methods can replace outdated 3+3 designs and drive faster, smarter early-phase oncology decisions.